









Mercados
/
Ações
/
nasdaq-mdt
/

Medtronic PLC

MDT

101.000USD

+0.210+0.21%

Fechamento 01/29, 16:00（ET）Cotações atrasadas em 15 min

129.48BValor de mercado

27.18P/L TTM



Medtronic PLC

101.000

+0.210+0.21%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Medtronic PLC Empresa

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Informações de Medtronic PLC



Código da empresaMDT

Nome da EmpresaMedtronic PLC

Data de listagemNov 21, 1977

CEOMartha (Geoffrey S)

Número de funcionários95000

Tipo de títulosOrdinary Share

Fim do ano fiscalNov 21

EndereçoBuilding Two Parkmore Business Park West

CidadeDUBLIN

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísIreland

Código postalH91 4K49

Telefone1135314381700

Sitehttps://www.medtronic.com/

Código da empresaMDT

Data de listagemNov 21, 1977

CEOMartha (Geoffrey S)

Executivos da empresa Medtronic PLC



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

-1564.00%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.17K

-439.00%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-3541.00%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+890.00%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

48.26K

-1371.00%

Mr. Craig Arnold

Lead Independent Director

40.24K

+73.00%

Mr. Scott C. Donnelly

Independent Director

21.71K

+192.00%

Dr. Elizabeth G. (Betsy) Nabel, M.D.

Independent Director

17.64K

+72.00%

Mr. Kevin E. Lofton

Independent Director

8.19K

+72.00%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

7.39K

-32060.00%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.90M

-1564.00%

Mr. Brett A. Wall

Executive Vice President, President - Neuroscience Portfolio

548.17K

-439.00%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-3541.00%

Mr. Kendall J. (Ken) Powell

Independent Director

48.84K

+890.00%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Americas

48.26K

-1371.00%

Mr. Craig Arnold

Lead Independent Director

40.24K

+73.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan

FY2026Q2

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Cardiac Rhythm & Heart Failure

1.82B

20.37%

Surgical & Endoscopy

1.68B

18.74%

Cranial & Spinal Technologies

1.30B

14.50%

Structural Heart & Aortic

956.00M

10.67%

Specialty Therapies

744.00M

8.30%

Outro

2.46B

27.43%

Por RegiãoUSD

Nome

Receita

Proporção

United States

4.52B

50.40%

Rest of World

4.41B

49.21%

Ireland

35.00M

0.39%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Cardiac Rhythm & Heart Failure

1.82B

20.37%

Surgical & Endoscopy

1.68B

18.74%

Cranial & Spinal Technologies

1.30B

14.50%

Structural Heart & Aortic

956.00M

10.67%

Specialty Therapies

744.00M

8.30%

Outro

2.46B

27.43%

Distribuição de ações

Atualizado em: seg, 17 de nov

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

10.01%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Investment Management (US)

4.72%

JP Morgan Asset Management

2.92%

Capital Research Global Investors

2.39%

Outro

74.78%

Investidores

Proporção

The Vanguard Group, Inc.

10.01%

BlackRock Institutional Trust Company, N.A.

5.18%

State Street Investment Management (US)

4.72%

JP Morgan Asset Management

2.92%

Capital Research Global Investors

2.39%

Outro

74.78%

Tipos de investidores

Investidores

Proporção

Investment Advisor

46.88%

Investment Advisor/Hedge Fund

29.43%

Research Firm

4.36%

Pension Fund

2.40%

Bank and Trust

2.16%

Hedge Fund

1.41%

Sovereign Wealth Fund

1.37%

Insurance Company

0.38%

Individual Investor

0.28%

Outro

11.33%

Participação acionária institucional



Atualizado em: qui, 1 de jan

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q4

3674

1.13B

88.21%

-17.18M

2025Q3

3723

1.13B

88.20%

-2.77M

2025Q2

3762

1.12B

87.12%

-18.03M

2025Q1

3818

1.13B

88.15%

+2.18M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

130.95M

10.21%

+4.49M

+3.55%

Nov 28, 2025

BlackRock Institutional Trust Company, N.A.

66.42M

5.18%

-1.42M

-2.10%

Sep 30, 2025

State Street Investment Management (US)

60.46M

4.72%

+625.99K

+1.05%

Sep 30, 2025

JP Morgan Asset Management

37.48M

2.92%

+11.18M

+42.48%

Sep 30, 2025

Capital Research Global Investors

30.69M

2.39%

-5.67M

-15.58%

Sep 30, 2025

Geode Capital Management, L.L.C.

27.65M

2.16%

-579.44K

-2.05%

Sep 30, 2025

MFS Investment Management

19.44M

1.52%

+75.05K

+0.39%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

16.44M

1.28%

+1.87M

+12.83%

Jun 30, 2025

Managed Account Advisors LLC

14.98M

1.17%

+1.21M

+8.79%

Sep 30, 2025

BlackRock Financial Management, Inc.

14.32M

1.12%

-1.30M

-8.33%

Sep 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

Absolute Select Value ETF

4.89%

iShares U.S. Medical Devices ETF

4.4%

iShares Health Innovation Active ETF

4.26%

Cullen Enhanced Equity Income ETF

4.24%

USCF Dividend Income Fund

3.59%

JPMorgan Healthcare Leaders ETF

3.22%

Madison Dividend Value ETF

3.08%

Tema Heart & Health ETF

2.98%

Global X Aging Population ETF

2.98%

WisdomTree US AI Enhanced Value Fund

2.86%

Ver Mais

Absolute Select Value ETF

Proporção4.89%

iShares U.S. Medical Devices ETF

Proporção4.4%

iShares Health Innovation Active ETF

Proporção4.26%

Cullen Enhanced Equity Income ETF

Proporção4.24%

USCF Dividend Income Fund

Proporção3.59%

JPMorgan Healthcare Leaders ETF

Proporção3.22%

Madison Dividend Value ETF

Proporção3.08%

Tema Heart & Health ETF

Proporção2.98%

Global X Aging Population ETF

Proporção2.98%

WisdomTree US AI Enhanced Value Fund

Proporção2.86%

Dividendo



Um total de 17.37B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Dec 04, 2025

MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 16, 2026 going ex on Dec 26, 2025 with reinvestment option

Dec 26, 2025

Jan 16, 2026

Dec 26, 2025

Aug 14, 2025

MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Oct 17, 2025 going ex on Sep 26, 2025 with reinvestment option

Sep 26, 2025

Oct 17, 2025

Sep 26, 2025

May 21, 2025

MDT.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 11, 2025 going ex on Jun 27, 2025 with reinvestment option

Jun 27, 2025

Jul 11, 2025

Jun 27, 2025

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

Ver Mais

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados

KeyAI

